UniSA Ventures manages the translation of IP through the establishment of spin-out companies in partnership with industry and investors.
Spin-out companies have strengthened the linkage between UniSA and industry. The growing number of technology patents and spin-outs coming out of UniSA research has a significant impact on regional, economic and social development.
AbRegen is a preclinical-stage biotechnology company developing first-in class antibody-based therapeutics to treat immuno-inflammatory conditions.
Read moreAUCENTRA Therapeutics discovers and develops oral small molecules for a range of cancers.
Read moreCarina Biotech is focused on research and IP development in chimeric antigen receptor T cell (CAR-T) technologies.
Read moreCincera Therapeutics is focused on the discovery and development of new drugs aiming to treat inflammatory and fibrotic conditions.
Read moreCohda Wireless is a world leader in Connected Autonomous Vehicle (CAV) technology, making our streets safer, smarter and greener.
Read moreFerronova is developing a system to less invasively and more accurately stage the spread of head and neck cancer.
Read moreMyriota are global leaders in low-cost, low-power, secure direct-to-orbit satellite connectivity for the Internet of Things.
Read moreSome of these cookies are essential for the website to function correctly, while others may collect your personal information. In some cases, the personal information collected by our cookies may be shared with third party service providers.
For details about the categories of cookies that we use, and to set your cookie preferences, please select ‘More information’ before you continue. For an overview see our Privacy Statement, or review our Privacy Policy in full.